Artificial organs developed by biohackers will soon deliver insulin to diabetics
In 2018, several hybrid closed-loop systems will begin to appear on the market. These will measure a user's blood-sugar levels every five minutes or so and supply insulin subcutaneously as appropriate. A large part of the R&D behind them was done in the open-source community. One such group, the Open Artificial Pancreas System project (OpenAPS), has for the past three years been encouraging diabetic biohackers to explore and improve their existing monitoring and insulin-delivery systems.
